COMPANY

Estrigenix Therapeutics, Inc.

Keywords: women's health dementia

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Seed · $2M · announced Jul 21, 2026 Company release ↗
Source quote
- Jul 21, 2026 · Company release ↗
  “MILWAUKEE (July 21, 2026) — Estrigenix Therapeutics today announced the first closing of its $2M Series Seed financing, led by Talents Fund I.”

Raises announced in these releases: $2M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Jul 21, 2026 Raise Private equity round — Seed: $2M (total, as published), announced Jul 21, 2026. Source: company's own press page. source ↗ · Form D filed Jul 27, 2026 SEC Form D ↗
Jul 21, 2026 Raise Seed · $2M source ↗

Raised: $2.0M. Last 2 years.

Jul 21, 2026 Private equity round — Seed: $2M (total, as published), announced Jul 21, 2026. Source: company's own press page. source ↗ · Form D filed Jul 27, 2026 SEC Form D ↗